REDX — Redx Pharma Share News
0.000.00%
- £35.01m
- £34.60m
- £4.20m
REG - Redx Pharma plc - Final Audited Results for Year Ended 30 September
AnnouncementREG - Redx Pharma plc - Notice of Preliminary Results
AnnouncementREG - Redx Pharma plc - Holdings in Company
AnnouncementREG - Redx Pharma plc - TR-1: Notification of major holdings
AnnouncementREG - Redx Pharma plc - TR-1: Notification of major holdings
AnnouncementREG - AIM - AIM Notice - 07/11/2023
AnnouncementREG - Redx Pharma plc - Admission of Subscription Shares and TVR
AnnouncementREG - Redx Pharma plc - Results of General Meeting
AnnouncementRCS - Redx Pharma plc - Redx Unveils Preclinical Data from RXC009
AnnouncementRCS - Redx Pharma plc - Redx to present preclinical data on RXC009 at ASN
AnnouncementREG - Redx Pharma plc - Proposed Subscription to raise c.£14.1 million
AnnouncementREG - Redx Pharma plc - Confirmation of Directorate Change
AnnouncementREG - Redx Pharma plc - Directorate Change
AnnouncementRCS - Redx Pharma plc - Zelasudil granted FDA Orphan Drug Designation
AnnouncementREG - Redx Pharma plc - Extension to Termination of Convertible Loan Notes
AnnouncementREG - Redx Pharma plc - Directorate Change
AnnouncementREG - Redx Pharma plc - New Grant of Options
AnnouncementRCS - Redx Pharma plc - Redx to present at Jefferies Healthcare Conference
AnnouncementREG - Redx Pharma plc - Interim Results for the Six Months Ended 31 March
Announcement